A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids

12.9K views

⸱

DOI:

10.3791/52885

⸱

June 5th, 2015

 ,  ,  ,  ,  ,  ,  ,  ,  , 

* These authors contributed equally

In This Article

Summary

Induced pluripotent stem cells (iPSCs) represent a source of patient-specific tissues for clinical applications and basic research. Here, we present a detailed protocol to reprogram human peripheral blood mononuclear cells (PBMNCs) obtained from frozen buffy coats into viral-free iPSCs using non-integrating episomal plasmids.

Abstract

Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by forcing the expression of four transcription factors (Oct-4, Sox-2, Klf-4, and c-Myc), typically expressed by human embryonic stem cells (hESCs). Due to their similarity with hESCs, iPSCs have become an important tool for potential patient-specific regenerative medicine, avoiding ethical issues associated with hESCs. In order to obtain cells suitable for clinical application, transgene-free iPSCs need to be generated to avoid transgene reactivation, altered gene expression and misguided differentiation. Moreover, a highly efficient and inexpensive reprogramming method is necessary to derive sufficient iPSCs for therapeutic purposes. Given this need, an efficient non-integrating episomal plasmid approach is the preferable choice for iPSC derivation. Currently the most common cell type used for reprogramming purposes are fibroblasts, the isolation of which requires tissue biopsy, an invasive surgical procedure for the patient. Therefore, human peripheral blood represents the most accessible and least invasive tissue for iPSC generation.

In this study, a cost-effective and viral-free protocol using non-integrating episomal plasmids is reported for the generation of iPSCs from human peripheral blood mononuclear cells (PBMNCs) obtained from frozen buffy coats after whole blood centrifugation and without density gradient separation.

Introduction

In 2006, the group of Shinya Yamanaka1 demonstrated for the first time that somatic cells from adult mice and humans can be converted into a pluripotent state by ectopic expression of four reprogramming factors (Oct-4, Sox-2, Klf-4, and c-Myc), generating the so-called Induced Pluripotent Stem Cells (iPSCs)2. Patient-specific iPSCs closely resemble human embryonic stem cells (hESCs) in terms of morphology, proliferation and ability to differentiate into the three-germ cell types (mesoderm, endoderm and ectoderm) while lacking the ethical concerns associated to the use of hESCs and bypassing possible immune rejection3. Thus, iPSCs appea....

Access restricted. Please log in or start a trial to view this content.

Protocol

Peripheral blood mononuclear cells (PBMNCs) were isolated from human peripheral blood samples of healthy donors after signed informed consent and approval of the Ethical Committee of the Province of South Tyrol. Experiments were conducted in accordance with the principles expressed in the Declaration of Helsinki. All data were collected and analyzed anonymously.

1. Isolation of Peripheral Blood Mononuclear Cells (PBMNCs)

  1. PBMNCs obtained from buffy coats after whole blood centrifugation, without density gradient separation.
    1. Collect 8 mL of venous peripheral blood into a sodium citrate buffered plastic tube, and store ....

Access restricted. Please log in or start a trial to view this content.

Results

In this study a simple and effective protocol for the generation of viral-free iPSCs by reprogramming of PBMNCs isolated from frozen buffy coats after whole blood centrifugation and comparison with reprogramming of PBMNCs obtained after density gradient separation is reported. Figure 1A shows a schematic representation of the detailed protocol. After thawing, the isolated PBMNCs, showing a typical rounded shape, are expanded in specific blood culture medium for 14 days (Figure 1B) and th.......

Access restricted. Please log in or start a trial to view this content.

Discussion

In the past, the only way to obtain human pluripotent stem cells carrying a particular genetic mutation was to recruit parents undergoing pre-implantation genetic diagnosis and generate embryonic stem cells from their discarded blastocysts31,32. Using a reprogramming approach, researchers can now generate iPSCs from patients carrying virtually any genotype. The possibility to start from a patient-specific cell line and an easily accessible source is very important since it allows an investigation of the pathop.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

The study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Sodium Citrate buffered Venosafe Plastic TubeTerumoVF-054SBCS07
Ammodium chlorideSigma-AldrichA9434
Potassium bicarbonateSigma-Aldrich60339
EDTA disodium powderSigma-AldrichE51340.5 M solution
Ficoll-Paque Premium GE Healthcare Life Sciences17-5442-02Polysucrose solution for density gradient centrifugation
Iscove's modified Dulbecco's medium (IMDM) Gibco21056-023No phenol red
Ham's F-12Mediatech10-080-CV
Insulin-Transferrin-Selenium-Ethanolamine (ITS -X)Gibco51500-056 1X (Stock: 100X)
Chemically Defined Lipid ConcentrateGibco119050311X (Stock: 100X)
Bovine Serum Albumin (BSA)Sigma-AldrichA9418
L-Ascorbic acid 2-phosphate sesquimagnesium salt hydrateSigma-AldrichA8960
1-ThioglycerolSigma-AldrichM6145Final Concentration at 200 µM
Recombinant Human Stem Cell Factor (SCF)PeproTech300-07100 ng/ml (Stock:100 µg/ml) 
Recombinant Human Interleukin-3 (IL-3)PeproTech200-0310 ng/ml (Stock: 10 µg/ml)
Recombinant Human Insulin-like Growth Factor (IGF-1)PeproTech100-1140 ng/ml (Stock: 40 µg/ml)
Recombinant Human Erythropoietin (EPO)R&D Systems 287-TC-5002 U/ml (Stock: 50 U/ml)
Dexamethasone Sigma-AldrichD29151 μM (Stock: 1 mM)
Human Holo-TransferrinR&D Systems 2914-HT100 μg/ml (Stock: 20 mg/ml)
Amniomax IIGibco11269016Medium for cytogenetic analysis
mTeSR1StemCell Technologies5850Medium for iPSC feeder-free culture
Knockout DMEMGibco10829-018
Knockout Serum ReplacementGibco10828-028
Penicillin-Streptomycin (10,000 U/mL)Gibco15140-122
L-Glutamine (200 mM)Gibco25030-024
MEM Non-Essential Amino Acids Solution (100X)Gibco11140-050
2-Mercaptoethanol Gibco31350-0100.1 mM (Stock: 50 mM)
Sodium ButyrateSigma-AldrichB58870.25 mM (Stock: 0.5 M)
Recombinant Human FGF basic, 145 aa R&D Systems 4114-TC10 ng/ml (Stock: 10 µg/ml)
Y-27632 dihydrochlorideSigma-AldrichY0503 10 µM (Stock: 10 mM)
Fetal Defined Bovine SerumHycloneSH 30070.03
EmbryoMax 0.1% Gelatin SolutionMerck-MilliporeES-006-B
Matrigel Basement Membrane Matrix Growth Factor ReducedBD Biosciences354230
Collagenase, Type IVGibco17104-0191 mg/ml (Stock: 10 mg/ml)
AccutasePAA Laboratories GmbHL11-007Cell detachment solution
Mouse Embryonic Fibroblast (CF1)Global StemGSC-6201G1*106 cells/6 well plate
Plasmid pCXLE-hOCT3/4-shp53-FAddgene 270771 µg (Stock: 1 µg/µl)
Plasmid pCXLE-hSKAddgene 270781 µg (Stock: 1 µg/µl)
Plasmid pCXLE-hULAddgene 270801 µg (Stock: 1 µg/µl)
Plasmid pCXLE-EGFPAddgene 270821 µg (Stock: 1 µg/µl)
Alkaline Phosphatase Staining KitStemgent00-0009
Anti-Stage-Specific Embryonic Antigen-4 (SSEA-4) AntibodyMerck-MilliporeMAB43041/250
Anti-TRA-1-60 AntibodyMerck-MilliporeMAB43601/250
Anti-TRA-1-81 AntibodyMerck-MilliporeMAB43811/250
Anti-Oct-3/4 AntibodySanta Cruz Biotechnologysc-90811/500
Anti-Nanog AntibodySanta Cruz Biotechnologysc-337591/500
Anti-Troponin I AntibodySanta Cruz Biotechnologysc-153681/500
Anti-α-Actinin (Sarcomeric) AntibodySigma-AldrichA77321/250
Neuronal Class III ß-Tubulin (TUJ1) AntibodyCovance Research Products Inc MMS-435P-1001/500
Anti-Tyrosine Hydroxylase (TH) AntibodyCalbiochem6570121/200
Alexa Fluor 488 Goat Anti-Mouse Molecular ProbesA-110291/1000
Alexa Fluor 555 Goat Anti-RabbitMolecular ProbesA-214291/1000
Ultra-Low Attachment Cell Culture 6-well plateCorning3471
Trizol ReagentAmbion15596-018 reagent for RNA extraction
SuperScript VILO cDNA Synthesis KitInvitrogen11754050Reverse transcriptase kit
iTaq Universal SYBR Green SupermixBio-Rad172-5124
CFX96 Real-Time PCR Detection SystemBio-Rad185-5195
Experion Automated Electrophoresis SystemBio-Rad700-7000Instrument to check RNA integrity
Experion RNA Highsense Analysis kitBio-Rad7007105Reagent kit to check RNA integrity
Dissecting microscope (SteREO Discovery V12 )Zeiss495007
NeonTransfection System 100 µl KitInvitrogenMPK10025Reagent kit for electroporation
Neon Transfection SystemInvitrogenMPK5000Instrument used for electroporation
NanoDrop UV/Vis SpectrophotometerThermo ScientificND-2000Instrument for DNA/RNA quantification
EndoFree Plasmid Maxi KitQiagen12362Plasmid purification kit

References

  1. Takahashi, K., Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126 (4), 663-676 (2006).
  2. Takahashi, K., Okita, K., Nakagawa, M., Yamanaka, S. Induction of pluripotent stem cells from f....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Peripheral Blood Mononuclear CellsBuffy Coat IsolationNon-integrating ReprogrammingElectroporation TransfectionMouse Embryonic Fibroblast FeedersImmunofluorescence AnalysisGene Expression MeasurementCost-effective Protocol